Agha Khan Medical University News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 
“After 48 days of vaccination so far, my physical condition is 100 percent fit. My body has not observed any change,” said Mr. Hussain, 54, who is a test subject amongst total of 18000 trial participants who received shots of CanSino during Pakistan’s first-ever massive Phase-III (Last Stage) Clinical Trials.
 
The Clinical Trials was conducted at solely public sector institution, the University of Health Sciences (UHS) officially approved by the government of Pakistan under strict guidelines of the World Health Organization (WHO).
 
“There was a bit sporadic feeling of nausea and throat nuisance but it lasted only a few seconds. Throughout the time span, my health stays uncompromised. Physical fitness is up and I am not running a fever or other medical issues,” he says loud and clear. ....

Wang Su , Agha Khan , Shehnoor Azhar , Yasir Habib Khan , Javed Akram , Shaheen Shah , World Health Organization Covid , World Health Organization , Institute Of Biotechnology China , People Vaccine Alliance , Agha Khan Medical University , University Of Health Sciences , Shifa International Hospital Islamabad , Scientific Task Force On Covid , Yasir Habib , Last Stage , Clinical Trials , Health Sciences , China Made Cansino , Clinical Trial , Shaukat Khanam Hospital , Shifa International Hospital , Indus Hospital , Scientific Task Force , China Economic Net , Good Clinical Practices ,